Editas Medicine (EDIT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 131,541 | 123,652 | 141,522 | 203,519 | 139,682 |
| Marketable Securities | 138,372 | 199,459 | 202,752 | 296,326 | 262,428 |
| Receivables | 16,266 | 10,187 | 5,145 | 267 | 6,048 |
| TOTAL | $289,315 | $340,829 | $356,754 | $507,310 | $419,087 |
| Non-Current Assets | |||||
| PPE Net | 14,497 | 12,032 | 15,569 | 17,118 | 14,020 |
| Investments And Advances | 0 | 104,024 | 93,097 | 120,071 | 109,664 |
| Other Non-Current Assets | 37,777 | 42,268 | 48,901 | 32,984 | 29,831 |
| TOTAL | $52,274 | $158,324 | $157,567 | $170,173 | $153,515 |
| Total Assets | $341,589 | $499,153 | $514,321 | $677,483 | $572,602 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,493 | 8,269 | 9,511 | 5,050 | 6,408 |
| Accrued Expenses | 45,859 | 34,563 | 31,296 | 20,192 | 24,046 |
| Other current liabilities | 5,000 | N/A | N/A | N/A | N/A |
| TOTAL | $77,225 | $63,217 | $60,110 | $46,884 | $58,208 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 6,221 | 8,221 | 8,221 | 11,333 | 20,943 |
| Other Non-Current Liabilities | 75,886 | 26,172 | 32,864 | 16,069 | 46,824 |
| TOTAL | $130,090 | $86,839 | $93,531 | $76,957 | $120,808 |
| Total Liabilities | $207,315 | $150,056 | $153,641 | $123,841 | $179,016 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 82,976 | 81,814 | 68,970 | 68,519 | 67,363 |
| Common Shares | 8 | 8 | 7 | 7 | 6 |
| Retained earnings | -1,468,443 | -1,231,350 | -1,078,131 | -857,699 | -665,197 |
| Other shareholders' equity | 268 | 198 | -3,601 | -493 | -46 |
| TOTAL | $134,274 | $349,097 | $360,680 | $553,642 | $393,586 |
| Total Liabilities And Equity | $341,589 | $499,153 | $514,321 | $677,483 | $572,602 |